Workday Inc
For the period ended Jan 31, 2024. Filed Mar 8, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 8, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Pleasanton, State of California, on this 8th day of March, 2024.
WORKDAY, INC.
/s/ Zane Rowe
Zane RoweChief Financial Officer (Principal Financial and Accounting Officer)
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Zane Rowe or Richard H. Sauer, or any of them, his or her attorneys-in-fact, for such person in any and all capacities, to sign any amendments to this report and to file the same, with exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that either of said attorneys-in-fact, or substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Carl M. Eschenbach | Chief Executive Officer | March 8, 2024 |
| Carl M. Eschenbach | (Principal Executive Officer) | |
| /s/ Zane Rowe | Chief Financial Officer | March 8, 2024 |
| Zane Rowe | (Principal Financial and Accounting Officer) | |
| /s/ Aneel Bhusri | Director | March 8, 2024 |
| Aneel Bhusri | ||
| /s/ Thomas F. Bogan | Director | March 8, 2024 |
| Thomas F. Bogan | ||
| /s/ Ann-Marie Campbell | Director | March 8, 2024 |
| Ann-Marie Campbell | ||
| /s/ Christa Davies | Director | March 8, 2024 |
| Christa Davies | ||
| /s/ Lynne M. Doughtie | Director | March 8, 2024 |
| Lynne M. Doughtie | ||
| /s/ Wayne A.I. Frederick, M.D. | Director | March 8, 2024 |
| Wayne A.I. Frederick, M.D. | ||
| /s/ Mark J. Hawkins | Director | March 8, 2024 |
| Mark J. Hawkins | ||
| /s/ Michael M. McNamara | Director | March 8, 2024 |
| Michael M. McNamara | ||
| /s/ George J. Still, Jr. | Director | March 8, 2024 |
| George J. Still, Jr. | ||
| /s/ Jerry Yang | Director | March 8, 2024 |
| Jerry Yang | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.